12 results  1 of 1 

1 Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
Hyun Hwan Sung, Jiwoong Yu, Su Jeong Kang, Mee Ree Chae, Insuk So, Jong Kwan Park, Sung Won Lee
World J Mens Health.2019;37(2):240-248.   Published online 2018 December 26     DOI: http://dx.doi.org/10.5534/wjmh.180082
      
2 Early dutasteride monotherapy in men with detectable serum prostate-specific antigen levels following radical prostatectomy: A prospective trial
Yu Seob Shin, Jea Whan Lee, Myung Ki Kim, Young Beom Jeong, Seung Chol Park
Investig Clin Urol.2017;58(2):98-102.   Published online 2017 February 15     DOI: http://dx.doi.org/10.4111/icu.2017.58.2.98
      
3 Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia
Gwang Seong Choi, Joon Hyung Kim, Shin-Young Oh, Jung-Min Park, Ji-Soo Hong, Yil-Seob Lee, Won-Soo Lee
Ann Dermatol.2016;28(4):444-450.   Published online 2016 July 26     DOI: http://dx.doi.org/10.5021/ad.2016.28.4.444
      
4 The Effect of Two Weeks of Treatment with Dutasteride on Bleeding after Transurethral Resection of the Prostate
Kyu Shik Kim, Won Sik Jeong, Sung Yul Park, Yong Tae Kim, Hong Sang Moon
World J Mens Health.2015;33(1):14-19.   Published online 2015 April 23     DOI: http://dx.doi.org/10.5534/wjmh.2015.33.1.14
      
5 Significance of intraprostatic architecture and regrowth velocity for considering discontinuation of dutasteride after combination therapy with an alpha blocker: A prospective, pilot study
Tetsuya Shindo, Kohei Hashimoto, Takashi Shimizu, Naoki Itoh, Naoya Masumori
Korean J Urol.2015;56(4):305-309.   Published online 2015 March 27     DOI: http://dx.doi.org/10.4111/kju.2015.56.4.305
      
6 Impact of Treatment With Statins on Prostate-Specific Antigen and Prostate Volume in Patients With Benign Prostatic Hyperplasia
Sang Hun Lee, Tae Ju Park, Min Ho Bae, Sung Ho Choi, Young Sam Cho, Kwan Joong Joo, Chil Hun Kwon, Heung Jae Park
Korean J Urol.2013;54(11):750-755.   Published online 2013 November 6     DOI: http://dx.doi.org/10.4111/kju.2013.54.11.750
      
7 Post-marketing Surveillance of the Safety of Dutasteride Prescribed to Korean Patients with Benign Prostate Hyperplasia
Joon Hyung Kim, Ji-Young Bae, Shin-Young Oh, Yil-Seob Lee
J Korean Soc Clin Pharmacol Ther.2012;20(1):85-94.   Published online 2012 June 30     DOI: http://dx.doi.org/10.12793/jkscpt.2012.20.1.85
      
8 Clinical Significance of Transrectal Ultrasonography and Efficacy of Dutasteride Treatment in Patients with Hemospermia
Young Jung Kim, Eu Chang Hwang, Sun Ouck Kim, Seung Il Jung, Taek Won Kang, Dong Deuk Kwon, Kwangsung Park, Soo Bang Ryu
Korean J Androl.2011;29(3):206-212.   Published online 2011 December 22     DOI: http://dx.doi.org/10.5534/kja.2011.29.3.206
   
9 Changes in Sexual Function in Benign Prostatic Hyperplasia Patients Taking Dutasteride: 1-Year Follow-Up Results
Byung Hoon Chi, Sae Chul Kim
Korean J Urol.2011;52(9):632-636.   Published online 2011 September 28     DOI: http://dx.doi.org/10.4111/kju.2011.52.9.632
      
10 The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride
Yong Hyeuk Choi, Sung Yong Cho, In Rae Cho
Korean J Urol.2010;51(10):704-708.   Published online 2010 October 21     DOI: http://dx.doi.org/10.4111/kju.2010.51.10.704
      
11 The Effect of Short Term Dutasteride Therapy on Microvessel Density in Benign Prostatic Hyperplasia
Je Hyeong Woo, Jeong Yoon Kang, Eun Kyung Kim, Tag Keun Yoo
Korean J Urol.2008;49(6):515-519.   Published online 2008 January 21     DOI: http://dx.doi.org/10.4111/kju.2008.49.6.515
   
12 The Change of Prostate-specific Antigen and Prostate-specific Antigen Density in Patients with Benign Prostatic Hyperplasia after Dutasteride Treatment
Byeong Seok Kim, Young Eun Yoon, Sang Bong Lee, Sung Yul Park, Young Woo Son, Yong Tae Kim, Hong Yong Choi, Hong Sang Moon
Korean J Urol.2008;49(10):893-898.   Published online 2008 January 20     DOI: http://dx.doi.org/10.4111/kju.2008.49.10.893
   

 1 of 1